Spectre Bio

Programmable biology without a genome

  • Biotech
Therapeutics

Member

Active

Status

2025

Founded

Seed

Development stage

  • EngBio3
    Accelerate

Spectre Bio is engineering bacterial-like particles, which are genome-inactivated, non-replicative microbial shells, as a safe bio-platform for diverse biomedical applications. Its core technology combines deep bioinformatics with synthetic biology, translating bacterial-like particles into rapid, effective prophylactics for high-burden infections, leveraging the immune system's localised memory.

Founding team

Key contacts